The telomerase reverse transcriptase gene (TERT) is essential for telomere stabilization and cell immortalization. A role for TERT promoter mutations C228T and C250T has been demonstrated in aggressive human cancer. The underlying mechanisms of telomerase activation is not known in adrenal tumors. Liu and colleagues assessed C228T and C250T TERT mutations, finding that TERT promoter mutation C228T is a recurrent event associated with adrenocortical carcinoma, but rarely occurs in paraganglioma or pheochromocytoma. The involvement of the TERT gene in adrenocortical carcinoma is a new finding.

Read the full article at Liu et al. (2014) Endocrine-Related Cancer 21 427–434; DOI:10.1530/ERC-14-0016

Related Links:

ConclusionsThese results suggest that inflammation-induced DNA methylation and silencing ofPolg plays an important role in the tumorigenesis process by resulting in reduced mitochondria levels and altered metabolism. An enhanced understanding of how metabolism is altered in and drives inflammation-induced tumorigenesis will provide potential therapeutic targets.

An update to guidelines from ASCO on the optimal management of patients with HER2+ breast cancer offers recommendations on timing and sequence of therapies.

Source: CancerNetworkCategory: Cancer & Oncology Authors: Source Type: news

Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancerRandomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer, Published online: 10 July 2018; doi:10.1038/s41416-018-0150-6Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

Source: British Journal of CancerCategory: Cancer & Oncology Authors: Source Type: research

ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer, Published online: 10 July 2018; doi:10.1038/s41416-018-0174-yERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer

Source: British Journal of CancerCategory: Cancer & Oncology Authors: Source Type: research

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases, Published online: 10 July 2018; doi:10.1038/s41416-018-0172-0Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

Source: British Journal of CancerCategory: Cancer & Oncology Authors: Source Type: research

Immunomodulatory role of histamine H4 receptor in breast cancer, Published online: 10 July 2018; doi:10.1038/s41416-018-0173-zImmunomodulatory role of histamine H4 receptor in breast cancer

Source: British Journal of CancerCategory: Cancer & Oncology Authors: Source Type: research

Publication date: 9 July 2018Source: Cancer Cell, Volume 34, Issue 1Author(s): A. Hunter Shain, Nancy M. Joseph, Richard Yu, Jamal Benhamida, Shanshan Liu, Tarl Prow, Beth Ruben, Jeffrey North, Laura Pincus, Iwei Yeh, Robert Judson, Boris C. BastianSummaryWe elucidated genomic and transcriptomic changes that accompany the evolution of melanoma from pre-malignant lesions by sequencing DNA and RNA from primary melanomas and their adjacent precursors, as well as matched primary tumors and regional metastases. In total, we analyzed 230 histopathologically distinct areas of melanocytic neoplasia from 82 patients. Somatic altera…

Source: Cancer CellCategory: Cancer & Oncology Source Type: research

Publication date: 9 July 2018Source: Cancer Cell, Volume 34, Issue 1Author(s): Zev A. Binder, Amy Haseley Thorne, Spyridon Bakas, E. Paul Wileyto, Michel Bilello, Hamed Akbari, Saima Rathore, Sung Min Ha, Logan Zhang, Cole J. Ferguson, Sonika Dahiya, Wenya Linda Bi, David A. Reardon, Ahmed Idbaih, Joerg Felsberg, Bettina Hentschel, Michael Weller, Stephen J. Bagley, Jennifer J.D. Morrissette, MacLean P. NasrallahSummaryWe explored the clinical and pathological impact of epidermal growth factor receptor (EGFR) extracellular domain missense mutations. Retrospective assessment of 260 de novo glioblastoma patients revealed a s…

Source: Cancer CellCategory: Cancer & Oncology Source Type: research

Publication date: 9 July 2018Source: Cancer Cell, Volume 34, Issue 1Author(s): Athena Georgilis, Sabrina Klotz, Christopher J. Hanley, Nicolas Herranz, Benedikt Weirich, Beatriz Morancho, Ana Carolina Leote, Luana D’Artista, Suchira Gallage, Marco Seehawer, Thomas Carroll, Gopuraja Dharmalingam, Keng Boon Wee, Marco Mellone, Joaquim Pombo, Danijela Heide, Ernesto Guccione, Joaquín Arribas, Nuno L. Barbosa-Morais, Mathias HeikenwalderSummaryOncogene-induced senescence is a potent tumor-suppressive response. Paradoxically, senescence also induces an inflammatory secretome that promotes carcinogenesis and age-rela…

Source: Cancer CellCategory: Cancer & Oncology Source Type: research

Publication date: 9 July 2018Source: Cancer Cell, Volume 34, Issue 1Author(s): Hanlin Zeng, Aparna Jorapur, A. Hunter Shain, Ursula E. Lang, Rodrigo Torres, Yuntian Zhang, Andrew S. McNeal, Thomas Botton, Jue Lin, Matthew Donne, Ingmar N. Bastian, Richard Yu, Jeffrey P. North, Laura Pincus, Beth S. Ruben, Nancy M. Joseph, Iwei Yeh, Boris C. Bastian, Robert L. JudsonSummaryLoss of the CDKN2A tumor suppressor is associated with melanoma metastasis, but the mechanisms connecting the phenomena are unknown. Using CRISPR-Cas9 to engineer a cellular model of melanoma initiation from primary human melanocytes, we discovered that a…

Source: Cancer CellCategory: Cancer & Oncology Source Type: research





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Enter Captcha Here : *

Reload Image